UCLA-led research results in FDA approval of 4-drug combination for frontline treatment of metastatic pancreatic cancer

A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil has been approved by the FDA for

Related Keywords

United States ,American ,Zev Wainberg ,Ipsen Pharmaceuticals ,Health Gi Oncology Program ,David Geffen School Of Medicine ,Drug Administration ,Health Jonsson Comprehensive Cancer Center ,American Cancer Society ,Denise Heady ,Jonsson Comprehensive Cancer ,David Geffen School ,Newswise ,Ancreatic Cancer Fda Approval Research ,University Of California ,Os Angeles Ucla ,Health Sciences ,